You may not have heard about it yet ? but you will.

The first mainstream media report was in a British newspaper report dated July 25, 2004. The headline read, Children to Get Jabs Against Drug Addiction. In it, we learn that a “radical scheme to vaccinate children against future drug addiction” is being considered by the British Government.1
Under the plan, doctors would “immunize children at risk of becoming smokers or drug users with an injection.”

The article claimed the scheme would function “similarly to the current nationwide Measles, Mumps and Rubella vaccination program. Childhood immunization would protect adults from the euphoria experienced by users, making drugs such as heroin and cocaine pointless to take.”

Is this the future of the drug war? A nightmare dystopia where children are inoculated against feeling forbidden euphoria?

Drugs as a disease

To much of the anti-drug crowd, drug use is a “cancer” ? an analogy used by Clinton’s Drug Czar Barry McCaffrey back in 1997.2 The view that use of illegal herbs and drugs is a “disease” is the basis for a great deal of drug war propaganda. Take, for example, this 2003 statement from the White House:

“[Drug Use] spreads because the vectors of contagion are not addicts in the street, but users who do not yet show the consequences of their drug habit. Last year, some 16 million Americans used an illegal drug on at least on a monthly basis, while 6.1 million Americans were in need of treatment. The rest, still in the ‘honeymoon’ phase of their drug-using careers, are ‘carriers’ who transmit the disease to others who see only the surface of the fraud.”3

To these anti-drug warriors, all use is abuse, and all euphoria that comes from plants is unnecessary. To them, any medicating against stress, depression or fatigue requires a doctor and carefully measured doses of synthetics, not self-measured doses of botanicals.

If drug use is not a choice but a “disease,” then it becomes frighteningly logical to use the standard treatments for a contagion, including “medications” and “immunizations” to protect against these illegal substances.

Compassionate coercion

Using surgery and chemistry to treat “deviant” people for their private, non-harmful behaviors is nothing new. From 1907-1978 over 60,000 Americans were forcibly sterilized under state sterilization laws. These laws targeted criminals as well as the mentally handicapped, people with low IQ’s and the mentally ill.4

Also, up until the mid-1970’s, many gay people in North America were “treated” for their “condition” with the “compassionate coercion” of drugs, and even sterilization.5

Today, people who have been arrested for drug offenses, people serving time behind bars or people who rely on public assistance ? disproportionately black or brown folk6 ? are likely to be the first targets of the neurocops.

Already, some courts in the US have conditioned a grant of probation for alcohol-related offenses on the probationer using the alcohol blocker Antabuse.7 With the prevalence of “drug courts” which make users choose between forced treatment and prison, how long will it be until we see pot smokers and cocaine snorters forced to take an anti-drug pills and vaccinations as a condition of their release?

Next, they’ll come for the kids. 97% of American school kids are already vaccinated as a precondition to attending school.8 Many people question the safety and effectiveness of vaccinations, yet parents who refuse to allow their children to be stuck with needles have been charged with neglect and even child abuse.9

And it’s not just the “hard drugs” they want to inoculate your children against. The US National Institute on Drug Abuse (NIDA) is currently offering up $3 million in grant money to encourage “development of safe and effective pharmacological treatments for cannabis-related disorders (CRDs)…” They claim that “targeting adolescents and young adults is particularly relevant in view of their disproportionate use patterns.”10

Already, reps for companies like DrugAbuse Sciences (DAS) salivate openly at the potential profits in the buzzkill market. DAS exists only to make pharmaceutical drugs which block the effects of banned herbs and drugs ? they make “anti-drug drugs.”

In an April 2001 interview with the Wall Street Reporter, DrugAbuse Sciences CEO Elizabeth Greetham was blunt in her assessment of the huge profits they expected from the anti-drug market.

“If we treat 300,000 patients for six months and charge typical daily therapy of around four dollars per day, which is the usual charge for new medications today, we can generate $250 million worth of revenues to DrugAbuse Sciences… We believe that addiction will be a multi-billion dollar market. DAS will only have to scratch the surface to be very successful for our investment group.”11

It’s easy to see their reason for confidence ? Clinton’s old Drug Czar General Barry McCaffrey is now on their Board of Directors.12

Overlooked problems

As with most prohibitionist projects, this one has yet to be thought all the way through, as there may be unwanted side effects resulting from vaccinating or medicating the whole human race from birth against the so-called scourge of plant-based euphoria.

First, these banned herbs and drugs are not inherently harmful, so we’re throwing our most important mind-tools away because of their potential for misuse. It’s like tossing out your hammer because someone else hit their thumb with it.

Secondly, what if these vaccines and medications interfere with the body’s ability to feel pain and pleasure naturally? Are we risking becoming a species of emotionless droids? The possible unforeseen negative effects on our psychological make-up is limitless.

Cannabis, for example, activates receptors in areas of the brain which regulate body movements, learning, memory, appetite, nausea, pain, sexual behavior, emotion and integration of sensory information.13 What if the anti-cannabis medicine kills more than just the munchies?

The researchers at the Center for Cognitive Liberty and Ethics argue there is good reason to be concerned:

“In 2003, Roxane Laboratories discontinued the sale and distribution of the opioid agonist ORLAAM, as a result of ‘increasing reports of severe cardiac-related adverse events.’ Given that CB1 (cannabis) receptors are 10 times more abundant in the brain than opioid receptors, the possibilities for adverse effects from blocking CB1 are clearly substantial.”14

A third issue is that blocking the effects of a given drug will not stop someone who wants to get high. If the effects of their favored substance are blocked, the user is more than likely to simply switch to another, potentially more harmful option.

Meet the Buzzkillers

There are three basic types of “Buzzkill” technology currently out there. Each acts in a different way to stop your brain from feeling the effects of a given substance.

Receptor Blockers: There are three sub-types of these. “Agonists” are compounds that enter and activate the receptor sites on brain cells, acting as a synthetic substitute. “Partial agonists” are a weak synthetic substitute that blocks part of the drug’s effect. The “antagonists” are those that block the receptor site without activating it at all ? “total buzzkill.”

Molecule Binders: These bind to the drug molecules in your bloodstream, stopping them from reaching your brain by making them to big to pass the blood-brain barrier.

Many of the “anti-drug vaccines” which are being studied work in this way. They stimulate your body to make antibodies which latch onto the drug molecules, thereby enlarging them so they can’t reach the brain.

Metabolism Modifiers: These react negatively with the substance in question, making you sick if you consume it. An example is Antabuse (disulfiram) which makes you vomit should you swallow alcohol.

Buzzkill tech in development

A recent report by the Center for Cognitive Liberty and Ethics outlined many of the new anti-drugs and vaccines in production.18 Here’s some of the most interesting:

Xenova, the British biotechnology firm, is working on the anti-cocaine molecule binder vaccine, “TA-CD.” In 1999, a study with human volunteers showed that injecting TA-CD created “antibody responses” which lasted almost three months. In 2003, Xenova began testing TA-CD in a clinical trial involving 132 human subjects. They expect to complete this study in 2005 and move into Phase III studies.

DrugAbuse Sciences is racing to develop DAS-431, a “cocaine vaccine” that the company aims to release in both an injectable form as well as an inhalable aerosol. DrugAbuse Sciences have brought us Buprenophine Depot ? a long-lasting injectable opioid receptor blocker (partial agonist).

The Scripps Research Institute in San Diego has developed a “super-virus,” tested on rats and reportedly “harmless to humans,” which produces proteins that can reduce or block the effects of cocaine. The medication is expected to be available within in the next two years in the form of a nasal spray.

Pliva and Odyssey pharmaceuticals have teemed up to bring us “Antabuse” ? a “metabolism modifier” against alcohol and cocaine-induced euphoria. Death is also a possible reaction (and has occurred) from using alcohol after taking this drug. Users must be careful, as many foods and medications contain alcohol. Even the alcohol in aftershave, shampoo and perfume ? absorbed through the skin ? can trigger a reaction.

Roxane Laboratory still has Methadone on tap. Methadone is the first and oldest synthetic opioid blocker (agonist), and was invented by German company IG Farben. Roxane also used to have ORLAAM ? another opioid blocker (mild agonist), but it was withdrawn from the market last year after being linked to heart attacks and other health problems.

Dupont Pharma has come out with “naltrexone” or “Trexan” or “Revia” ? a heroin antagonist that, unlike methadone, produces no pleasurable effects. It is also being used for alcohol attraction, and is being tested for use against cocaine attraction. People taking this drug are advised to carry a card advising emergency medical personnel that most pain medications will be useless for them. There also is some indication that people on this drug get “higher” on marijuana ? but we sure don’t advise anyone to risk taking it to find out.

Catalist Pharmaceutical Partners has Vigabatrin to save us from cocaine and nicotine attraction.

GlaxoSmithKline have Nicorette, a nicotine-filled chewing gum that some people use to stop smoking, and others use to replace smoking. They also produce Zyban, an anti-depressant used to treat nicotine dependence, and which is currently being tested as an anti-meth drug.

Nabi pharmaceuticals is about to come out with NicVax ? the nicotine molecule binder vaccine. This would be used to inoculate children against ever being able to enjoy a tobacco cigarette.

Sanofi-Synthelabo is putting the final touches on Rimonabant, a cannabinoid antagonist which will be used to treat overeaters by blocking their innate cannabis receptors and killing their natural munchies. Rimonabant is also being looked at as a potential treatment for “marijuana dependence.”

One more bit of info to add is that Sanofi-Synthelabo, the maker of Rimonabant, is now known as “Sanofi Aventis.”19 Aventis merged with Bayer in 2001.20 Bayer is also marketing Sativex (a cannabis-based proprietary medicine) for GW Pharmaceuticals, and has ties to Solvay Pharma, the current makers of a synthetic THC pill called Nabalone.21 Bayer also has one of the worst records of crimes against humanity of any corporation on earth,22 and is a major donor to the Partnership for a Drug Free America.

Involuntary treatment = mistreatment

As past Mayor of Vancouver Phillip Owen recently pointed out, most of those in “drug treatment” are there “because of the system” ? because they were forced to choose between treatment and jail.15

This is backed up by research from the US Department of Health and Human Services, which states that 57% of those in drug treatment “were referred to treatment through the criminal justice system.”16

Many of the rest were coerced into treatment by their family or employer. The Center for Cognitive Liberty and Ethics estimates that “less than three percent of marijuana smokers voluntarily seek treatment.”14

Of course the White House argues we’re all “in denial” and in need of “compassionate coercion,” taking the form of “innovative techniques” using “specialized pharmaceuticals.”17

It’s one thing for an adult to voluntarily choose a particular treatment, but to subject infants to anti-euphoria vaccines or to medicate anyone against their will is an affront to human autonomy and a threat to every kind of human freedom. If buzzkill tech is accepted into common use, humans can officially stop considering themselves as “intelligent life” and place themselves in the category of “livestock.”

All human beings need to have the ability to feel good and the right to feel good, and, within limits involving harm to others, we have the right to feel good whenever and however we want to. Autonomy is an essential part of health.

We do not want to live in a world where our diet and medicine is dictated to us by the state ? a dark and horrible future if ever there was one.

? Some of the information in this article was derived from a report by the Center for Cognitive Liberty and Ethics: Threats to Cognitive Liberty: Pharmacotherapy and the Future of the Drug War;
? Pot-TV on Buzzkill:
? For more on dangers of vaccines, read Emerging Viruses and Death in the Air, by Dr Leonard Horowitz.

1) The Independent on Sunday. July 25, 2004.
2) 1997 National Drug Control Strategy
3) 2003 National Drug Control Strategy
4) Reilly, PR. The Surgical Solution: A History of Involuntary Sterilization in the United States. 1991. John Hopkins UP. p.87 See also:
5) Painter, George. The Sensibilities of Our Forefathers: The History of Sodomy Laws in the United States. 2003.
6) Key Recommendations from Punishment and Prejudice: Racial Disparities in the War on Drugs. 2000. Wash DC: Human Rights Watch.
7) Antabuse Medication in Exchange for a Limited Freedom ? is it Legal? American Journal of Law & Medicine, 5(4): 295-330.
8) Vaccination Coverage Among Children Enrolled in Head Start Programs and Licensed Child Care Centers and Entering School. Center for Disease Control, 2001
9) In the Matter of Christine M, 595, 606-7. NY, 1992. See also:
10) Medications Development for Cannabis-related Disorder. Request For Applications #RFA-DA-04-014 (December 1, 2003).
11) Private Company Profile: Drug Abuse Sciences, Inc. April 9, 2001. Wall Street Reporter.
12) Drug Abuse Sciences. July 24, 2001.
13) The Brain’s Own Marijuana. Scientific American. December 2004.
15) Mayor Philip Owen, interview on City Pulse TV, November 2001.
16) National Admissions to Substance Abuse Treatment Services, Department of Health and human Services
17) Healing America’s Drug Users: Getting Treatment Resources Where They Are Needed. National Drug Control Strategy. 2003
18) Threats to Cognitive Liberty: Pharmacotherapy and the Future of the Drug War, Center for Cognitive Liberty and Ethics.